Search
for
Sort by
Research 211–240 of 1000+
- Special Stains and Immunohistochemical Stains in Hair Pathology
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy
- Humanized CXCL12 antibody delays onset and modulates immune response in alopecia areata mice: insights from single-cell RNA sequencing
- Wound Healing: A Cellular Perspective
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure
- Image 1_Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata.pdf
- Melanocytes and Vitiligo (and Hair Graying)
- Tertiary Lymphoid Organs at the Center Stage of Skin's Humoral Immunity
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Nanomedicine-based immunotherapy for tissue regeneration
- Unveiling the Potential of Single‐Cell Encapsulation in Biomedical Applications: Current Advances and Future Perspectives
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- MicroRNA in skin diseases
- Twenty-Nail Dystrophy Treated with Hydroxychloroquine in a Patient with Alopecia Areata
- HAIR FOLLICLE STEM CELLS IN THE PATHOGENESIS OF PRIMARY CICATRICIAL ALOPECIA
- Epidemiology and burden of alopecia areata: a systematic review
- Study the correlation between Helicobacter pylori and insulin resistance in a group of women with polycystic ovarian syndrome in Baghdad city
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Hydroa Vacciniforme with Mucosal Involvement and Recalcitrant Periodontitis and Multiple Virus Re-activators after Sun-exposure
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Assessment of Interleukin-17A and Interleukin-2 Serum Levels in Patients with Alopecia Areata
- Vandetanib-associated alopecia areata in a patient with metastatic medullary thyroid cancer
- Ottawa, Ontario, Canada, February 13–16, 2013
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
- Assessment of Thyroid Dysfunction and Cortisol Levels in Patients with Alopecia Areata
- Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients